ATE171621T1 - Verwendung von 2-phenyl-1,2-benzisoselenazol- 3(2h)-on - Google Patents

Verwendung von 2-phenyl-1,2-benzisoselenazol- 3(2h)-on

Info

Publication number
ATE171621T1
ATE171621T1 AT91914052T AT91914052T ATE171621T1 AT E171621 T1 ATE171621 T1 AT E171621T1 AT 91914052 T AT91914052 T AT 91914052T AT 91914052 T AT91914052 T AT 91914052T AT E171621 T1 ATE171621 T1 AT E171621T1
Authority
AT
Austria
Prior art keywords
benzisoselenazol
phenyl
ebselen
cisplatin
reducing
Prior art date
Application number
AT91914052T
Other languages
English (en)
Inventor
Glenn S Baldew
N P E Vermeulen
Original Assignee
Rhone Poulenc Rorer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Gmbh filed Critical Rhone Poulenc Rorer Gmbh
Application granted granted Critical
Publication of ATE171621T1 publication Critical patent/ATE171621T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT91914052T 1990-08-06 1991-07-31 Verwendung von 2-phenyl-1,2-benzisoselenazol- 3(2h)-on ATE171621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4024885A DE4024885C2 (de) 1990-08-06 1990-08-06 Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on

Publications (1)

Publication Number Publication Date
ATE171621T1 true ATE171621T1 (de) 1998-10-15

Family

ID=6411708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914052T ATE171621T1 (de) 1990-08-06 1991-07-31 Verwendung von 2-phenyl-1,2-benzisoselenazol- 3(2h)-on

Country Status (8)

Country Link
EP (1) EP0542807B1 (de)
JP (1) JP3084062B2 (de)
AT (1) ATE171621T1 (de)
CA (1) CA2088760C (de)
DE (2) DE4024885C2 (de)
DK (1) DK0542807T3 (de)
ES (1) ES2123510T3 (de)
WO (1) WO1992002221A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
ES2145065T3 (es) 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
ES2177849T3 (es) * 1996-08-27 2002-12-16 Nattermann A & Cie Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.
DE19825746A1 (de) 1998-06-09 1999-12-16 Biosyn Arzneimittel Gmbh Kombination von Selen-haltigen Verbindungen mit Zytostatika
CN1166651C (zh) * 2001-06-08 2004-09-15 北京大学药学院 具有抗炎和抗肿瘤作用r-双或糖苯丙异硒唑取代化合物
PL370867A1 (en) * 2001-09-24 2005-05-30 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
EP1461033B1 (de) 2001-11-29 2013-02-27 Sound Pharmaceuticals Incorporated Verfahren und zusammensetzungen zur linderung von unerwünschten wirkungen einer chemotherapie
US6815434B2 (en) 2002-01-04 2004-11-09 Sound Pharmaceuticals Incorporated Methods for treating hearing loss
KR20070113262A (ko) * 2005-03-08 2007-11-28 사운드 파마슈티칼스 인코퍼레이티드 암의 치료 방법 및 암 치료용 조성물
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
DE3821392A1 (de) * 1988-06-24 1989-12-28 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)

Also Published As

Publication number Publication date
CA2088760C (en) 2002-05-07
JP3084062B2 (ja) 2000-09-04
JPH05509309A (ja) 1993-12-22
ES2123510T3 (es) 1999-01-16
EP0542807B1 (de) 1998-09-30
DE69130292T2 (de) 1999-04-08
DK0542807T3 (da) 1999-06-21
DE4024885A1 (de) 1992-02-13
DE69130292D1 (de) 1998-11-05
WO1992002221A1 (en) 1992-02-20
DE4024885C2 (de) 2002-07-18
CA2088760A1 (en) 1993-02-01
EP0542807A1 (de) 1993-05-26

Similar Documents

Publication Publication Date Title
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
FI925211A0 (fi) Isoxazol-4-karboxylsyraamider och hydroxialkylidencyanaettiksyraamider,laekemedel innehaollande dessa och anvaendning av dessa
WO1992007830A3 (en) Oxindole peptide antagonists
NZ508268A (en) Bicyclic pyrimidines and bicyclic 3,4- dihydropyrimidines as inhibitors of cellular proliferation
DE69130292D1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
CY1954A (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
NO159601C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-ketoandrostener.
MXPA02006217A (es) 2-(ih-indol-3-il)-2-oxo-acetamidas con actividad antitumoral.
ES453420A1 (es) Un procedimiento para la preparacion de nuevas benzoisotia- zolonas.
DK1014990T3 (da) Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin
DE69127713D1 (de) Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten
NZ336804A (en) Use of pramipexole in the treatment of restless legs syndrome
NO894281L (no) Stabile parenterale opploesninger av 2-fenyl-1,2-benzisoselenazol-3(h)-on og fremgangsmaate for fremstilling av samme.
ATE167804T1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
ATE129712T1 (de) Substituierte pyrido-oxazine.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
DE69015344D1 (de) Phosphatzusammensetzungen, gesinterter Körper davon und Herstellung dieses gesinterten Körpers.
DE68900867D1 (de) 1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung
ATE67992T1 (de) In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften.
EP0270841A3 (de) 2-Methyl-3-(p-methyl-phenyl)-propionitril, dessen Herstellung und Verwendung als Riechstoff
ATE303158T1 (de) Verwendung von beta-interferon zur behandlung der restenose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time